19004 Investors following Orchid Chemical. Share this News with them.
0
Like this story, share it with millions of investors on M3
Orchid receives US FDA approval for Cefuroxime Axetil ANDA
Orchid Chemicals & Pharmaceuticals Ltd announced that it has received approval from the US FDA for its ANDA for Cefuroxime Axetil Tablets. The product is available in three dosage strengths, 125 mg, 250 mg and 500 mg.
The Chennai-based pharma major, Orchid Chemicals & Pharmaceuticals Ltd (Orchid) today announced that it has received approval from the US FDA for its ANDA (Abbreviated New Drug Application) for Cefuroxime Axetil Tablets. The product is available in three dosage strengths, 125 mg, 250 mg and 500 mg.
This is the 25th ANDA approval that Orchid has received since it started its US Generics journey in 2005.
